Recent News:

October 17, 2023—Narcolepsy Network would like to share recent news from Neurology Live regarding recent findings from Harmony Biosciences’ Phase 3 INTUNE Study Evaluating Pitolisant in Patients with Idiopathic Hypersomnia.

September 7, 2023—Narcolepsy Network would like to share a press release that is posted on Harmony Biosciences’ website. This press release indicates Food & Drug Administration orphan drug designation for pitolisant for treatment of idiopathic hypersomnia.

March 30, 2023—Narcolepsy Network would like to share a press release that is posted on Jazz Pharmaceuticals’ website. This press release indicates that Jazz Pharmaceuticals is expanding support of the American Heart Association to raise awareness of the link between sleep disorders and heart health.